X
Edition:
India

  • Business
    • Business Home
    • Economy
    • Reuters Summits
    • Deals
    • Business Video
    • Company Results & Outlooks
    • Autos
  • Markets
    • Markets Home
    • Indices
    • Stock Quotes
    • India Markets
    • US Markets
    • Currencies
    • Commodities
    • Funds
  • India
    • Top News
    • India Insight
    • Monsoon
    • Top News Video
  • World
    • World Home
    • South Asia
    • Middle East
    • Special Reports
    • Reuters Investigates
    • World Video
  • Tech
    • Technology Home
    • Science
    • Tech Video
    • Innovation
  • Commentary
    • Commentary Home
    • Expert Zone
    • Macroscope
  • Breakingviews
    • Breakingviews Home
    • Breakingview Videos
  • Money
    • Money Home
    • Stock Screener
    • Fund Screener
  • Rio 2016
  • Pictures
    • Pictures Home
    • The Wider Image
    • Photographers
    • Focus 360
  • Video
More evidence 'poppers' may damage eyesight
  • Africa
    América Latina
  • عربي
    Argentina
  • Brasil
    Canada
  • 中国
    Deutschland
  • España
    France
  • India
    Italia
  • 日本
    México
  • РОССИЯ
    United Kingdom
  • United States
Health | Tue Jul 8, 2014 10:38pm IST

More evidence 'poppers' may damage eyesight

By Krystnell Storr

(Reuters Health) - A club drug and aphrodisiac since the 1970s, inhaled “poppers” are increasingly linked to eye damage - possibly due to a new formulation - according to a short report from the UK.

The case study describes a 30-year-old white male who developed vision loss in both eyes after inhaling poppers. The researchers noticed subtle changes in the form of yellow spots on the macula deep inside the man’s eye, but they say it’s still unclear just how the drug may be destroying vision.

“Over the past 18 months or so I have come across almost 10 patients with poppers maculopathy, whilst several years ago I had not even heard of the condition, same with a lot of my colleagues,” said Dr. Anna Gruener, a physician at Guy’s and St Mary’s Foundation Trust in London.

“I felt it was important to raise the issue and increase awareness,” she told Reuters Health.

The liquid drug, which becomes gas at room temperature, is sold in small vials and inhaled for a “rush” of euphoria. Among other effects, the drug dilates blood vessels and relaxes muscles, for about five minutes.

“People came up with the name ‘poppers’ as the lids or caps of the glass vials or tubes that contained the liquid had to be ‘popped off’ before the contents could be inhaled,” Gruener said.

She added that poppers in one form or another have been around for ages and were already widely used in the gay community in the 1970s. “People seemed to regard poppers as relatively safe, and visual loss from inhalation of poppers was unheard of,” she said.

Then in 2010 and 2011, some French ophthalmologists described multiple patients who had suffered from central visual loss following inhalation of poppers, and in 2012, the first UK case series was published.

Gruener thinks this sudden emergence of poppers maculopathy in Europe was most likely linked to a change in the type of nitrite chemicals used in poppers. Before a 2007 European Union law banned it, isobutyl nitrate was the most commonly used fluid in poppers. Now they are most often made with isopropyl nitrate.

It is possible, she said, this different chemical, for whatever reason, was more toxic to the retina than the one previously used.

The easy availability and widespread use of the drug is cause for concern, given the effects it can have on the eyes, Gruener’s team writes in The Lancet.

Not everyone reacts to poppers in the same way and while one person may use poppers repeatedly without any side effects, others may lose their vision after just one use, Gruener pointed out.

She added that some patients might see improvement in their vision after they stop using poppers while others can suffer irreversible vision loss.

There isn’t a lot of research into poppers for several reasons, she said. Many health care professionals still haven't heard of poppers or poppers maculopathy, and despite the increase in cases, the condition is relatively rare, plus it is a self-inflicted condition caused by recreational drug use and nothing else.

“I would like people to realize that poppers can potentially be very damaging, that there is no cure for poppers maculopathy and that prevention - avoidance of poppers - is therefore key,” she said.

SOURCE: bit.ly/1j8OtuM The Lancet, online June 20, 2014.

Trending Stories

    India at Rio

    Silver medal success turns Sindhu into hot property

    Sponsored Topics

    Next In Health

    Even with insurance, less affluent kids miss out on eye care

    (Reuters Health) - Middle- and lower-income children don’t visit eye doctors as often as wealthier kids, and as a result, thousands of them may have undiagnosed sight-threatening conditions, U.S. researchers say.

    Hospice teams may be overlooking teenaged family members

    (Reuters Health) - Teens with dying parents don’t benefit as much from hospice services as older members of the family do, a new study suggests.

    Up to 270 microcephaly cases expected in Puerto Rico due to Zika: officials

    CHICAGO U.S. health experts estimate that as many as 270 babies in Puerto Rico may be born with the severe birth defect known as microcephaly caused by Zika infections in their mothers during pregnancy.

    MORE FROM REUTERS

    From Around the Web By Taboola

    Sponsored Content By Dianomi

    X
    Follow Reuters:
    • Follow Us On Twitter
    • Follow Us On Facebook
    • RSS
    • Follow Us On LinkedIn
    Subscribe: Newsletters | Apps
    Reuters News Agency | Brand Attribution Guidelines | Delivery Options

    Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Learn more about Thomson Reuters products:

    Eikon
    Information, analytics and exclusive news on financial markets - delivered in an intuitive desktop and mobile interface
    Elektron
    Everything you need to empower your workflow and enhance your enterprise data management
    World-Check
    Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks
    Westlaw
    Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology
    ONESOURCE
    The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs
    CHECKPOINT
    The industry leader for online information for tax, accounting and finance professionals

    All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

    • Site Feedback
    • Corrections
    • Advertise With Us
    • Advertising Guidelines
    • AdChoices
    • Terms of Use
    • Privacy Policy